ArticleNeuro-oncology2011

Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma.

Oliver Bähr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.